Logo image of RLX

RLX TECHNOLOGY INC-ADR (RLX) Stock Fundamental Analysis

NYSE:RLX - New York Stock Exchange, Inc. - US74969N1037 - ADR

2.29  +0.02 (+0.88%)

After market: 2.29 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RLX. RLX was compared to 8 industry peers in the Tobacco industry. While RLX has a great health rating, its profitability is only average at the moment. RLX is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

RLX had positive earnings in the past year.
RLX had a positive operating cash flow in the past year.
Of the past 5 years RLX 4 years were profitable.
Each year in the past 5 years RLX had a positive operating cash flow.
RLX Yearly Net Income VS EBIT VS OCF VS FCFRLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.99%, RLX is in line with its industry, outperforming 50.00% of the companies in the same industry.
RLX's Return On Equity of 4.17% is fine compared to the rest of the industry. RLX outperforms 75.00% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 4.17%
ROIC N/A
ROA(3y)8.15%
ROA(5y)4.92%
ROE(3y)9.22%
ROE(5y)12.83%
ROIC(3y)N/A
ROIC(5y)N/A
RLX Yearly ROA, ROE, ROICRLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1.3 Margins

RLX's Profit Margin of 29.69% is amongst the best of the industry. RLX outperforms 87.50% of its industry peers.
RLX has a Gross Margin (24.75%) which is in line with its industry peers.
RLX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 29.69%
GM 24.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.14%
GM growth 5Y-11.35%
RLX Yearly Profit, Operating, Gross MarginsRLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

7

2. Health

2.1 Basic Checks

RLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RLX has less shares outstanding
Compared to 5 years ago, RLX has less shares outstanding
Compared to 1 year ago, RLX has a worse debt to assets ratio.
RLX Yearly Shares OutstandingRLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
RLX Yearly Total Debt VS Total AssetsRLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

RLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z N/A
ROIC/WACCN/A
WACC7.51%
RLX Yearly LT Debt VS Equity VS FCFRLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 5B 10B 15B

2.3 Liquidity

RLX has a Current Ratio of 14.38. This indicates that RLX is financially healthy and has no problem in meeting its short term obligations.
RLX has a better Current ratio (14.38) than 100.00% of its industry peers.
RLX has a Quick Ratio of 14.25. This indicates that RLX is financially healthy and has no problem in meeting its short term obligations.
RLX has a better Quick ratio (14.25) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 14.38
Quick Ratio 14.25
RLX Yearly Current Assets VS Current LiabilitesRLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 773.35% over the past year.
The Revenue has grown by 89.23% in the past year. This is a very strong growth!
RLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 64.28% yearly.
EPS 1Y (TTM)773.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.99%
Revenue 1Y (TTM)89.23%
Revenue growth 3Y-25.39%
Revenue growth 5Y64.28%
Sales Q2Q%76.67%

3.2 Future

Based on estimates for the next years, RLX will show a very strong growth in Earnings Per Share. The EPS will grow by 29.51% on average per year.
Based on estimates for the next years, RLX will show a very strong growth in Revenue. The Revenue will grow by 46.40% on average per year.
EPS Next Y58.16%
EPS Next 2Y39.72%
EPS Next 3Y29.51%
EPS Next 5YN/A
Revenue Next Year78.09%
Revenue Next 2Y61.25%
Revenue Next 3Y46.4%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RLX Yearly Revenue VS EstimatesRLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
RLX Yearly EPS VS EstimatesRLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.08 indicates a rather expensive valuation of RLX.
RLX's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.29. RLX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 19.34 indicates a rather expensive valuation of RLX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RLX is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of RLX to the average of the S&P500 Index (24.44), we can say RLX is valued slightly cheaper.
Industry RankSector Rank
PE 19.08
Fwd PE 19.34
RLX Price Earnings VS Forward Price EarningsRLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

RLX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 47.09
EV/EBITDA N/A
RLX Per share dataRLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

RLX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RLX's earnings are expected to grow with 29.51% in the coming years.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y39.72%
EPS Next 3Y29.51%

More info and screens

1

5. Dividend

5.1 Amount

RLX has a yearly dividend return of 0.36%, which is pretty low.
RLX's Dividend Yield is slightly below the industry average, which is at 4.64.
With a Dividend Yield of 0.36, RLX pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.36%

5.2 History

RLX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
RLX Yearly Dividends per shareRLX Yearly Dividends per shareYearly Dividends per share 2023 2024 0 0 0.01 0.01

5.3 Sustainability

RLX pays out 14.15% of its income as dividend. This is a sustainable payout ratio.
DP14.15%
EPS Next 2Y39.72%
EPS Next 3Y29.51%
RLX Yearly Income VS Free CF VS DividendRLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B 2.5B
RLX Dividend Payout.RLX Dividend Payout, showing the Payout Ratio.RLX Dividend Payout.PayoutRetained Earnings

More info and screens

RLX TECHNOLOGY INC-ADR

NYSE:RLX (1/21/2025, 8:24:14 PM)

After market: 2.29 0 (0%)

2.29

+0.02 (+0.88%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)11-15 2024-11-15/bmo
Earnings (Next)N/A N/A
Inst Owners28.21%
Inst Owner Change0.01%
Ins Owners45.11%
Ins Owner ChangeN/A
Market Cap3.60B
Analysts82.5
Price Target3.47 (51.53%)
Short Float %6.65%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield 0.36%
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP14.15%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.7%
Min EPS beat(2)-9.79%
Max EPS beat(2)-1.61%
EPS beat(4)2
Avg EPS beat(4)39.63%
Min EPS beat(4)-9.79%
Max EPS beat(4)128.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.48%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)3.68%
Revenue beat(4)2
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-19.53%
Max Revenue beat(4)7.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.86%
PT rev (3m)6.68%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 19.08
Fwd PE 19.34
P/S 11.92
P/FCF 47.09
P/OCF 44.5
P/B 1.67
P/tB 1.69
EV/EBITDA N/A
EPS(TTM)0.12
EY5.24%
EPS(NY)0.12
Fwd EY5.17%
FCF(TTM)0.05
FCFY2.12%
OCF(TTM)0.05
OCFY2.25%
SpS0.19
BVpS1.37
TBVpS1.36
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 4.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 29.69%
GM 24.75%
FCFM 25.31%
ROA(3y)8.15%
ROA(5y)4.92%
ROE(3y)9.22%
ROE(5y)12.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.14%
GM growth 5Y-11.35%
F-Score5
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 85.24%
Current Ratio 14.38
Quick Ratio 14.25
Altman-Z N/A
F-Score5
WACC7.51%
ROIC/WACCN/A
Cap/Depr(3y)142.73%
Cap/Depr(5y)678.29%
Cap/Sales(3y)1.5%
Cap/Sales(5y)2.19%
Profit Quality(3y)47.95%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)773.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.99%
EPS Next Y58.16%
EPS Next 2Y39.72%
EPS Next 3Y29.51%
EPS Next 5YN/A
Revenue 1Y (TTM)89.23%
Revenue growth 3Y-25.39%
Revenue growth 5Y64.28%
Sales Q2Q%76.67%
Revenue Next Year78.09%
Revenue Next 2Y61.25%
Revenue Next 3Y46.4%
Revenue Next 5YN/A
EBIT growth 1Y20.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year253.54%
EBIT Next 3Y75.27%
EBIT Next 5YN/A
FCF growth 1Y-73.19%
FCF growth 3Y-59.86%
FCF growth 5YN/A
OCF growth 1Y-71.63%
OCF growth 3Y-57.51%
OCF growth 5YN/A